US court refuses Ranbaxy appeal to block ANDA nod for 2 drugs
Drug firm Ranbaxy Laboratories on Wednesday said the DC Federal Court in the US has not granted the company temporary restraining order to block the US health regulator from approving other ANDAs for generic versions of digestive disorder medicine Nexium and anti-viral Valcyte.
Nov 26, 2014, 14:26 PM IST